PubMed

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL.

Ann Intern Med. 2000 Jul 4;133(1):1-9.PMID: 10877734 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.

Huledal G, Jonzon B, Malmenäs M, Hedman A, Andersson LI, Odlind B, Brater DC.

Clin Pharmacol Ther. 2005 May;77(5):437-50.PMID: 15900289 [PubMed - indexed for MEDLINE]Related articles

COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin.

Sigthorsson G, Crane R, Simon T, Hoover M, Quan H, Bolognese J, Bjarnason I.

Gut. 2000 Oct;47(4):527-32.PMID: 10986213 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.

Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K.

Clin Pharmacol Ther. 2002 Jul;72(1):50-61.PMID: 12152004 [PubMed - indexed for MEDLINE]Related articles

Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.

Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, Kwong E, Evans JF, Wolfe MM.

Cancer Res. 2003 Feb 1;63(3):586-92.PMID: 12566300 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, FitzGerald GA.

J Pharmacol Exp Ther. 1999 May;289(2):735-41.PMID: 10215647 [PubMed - indexed for MEDLINE]Related articlesFree article

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.

Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, Porras A, Wittreich J, Seibold JR, De Schepper P, Mehlisch DR, Gertz BJ.

Clin Pharmacol Ther. 1999 Mar;65(3):336-47.PMID: 10096266 [PubMed - indexed for MEDLINE]Related articles

Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.

Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR.

Circulation. 2004 Aug 24;110(8):934-9. Epub 2004 Aug 9.PMID: 15302800 [PubMed - indexed for MEDLINE]Related articlesFree article

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.

JAMA. 2000 Sep 13;284(10):1247-55.PMID: 10979111 [PubMed - indexed for MEDLINE]Related articlesFree article

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial.

Laine L, Maller ES, Yu C, Quan H, Simon T.

Gastroenterology. 2004 Aug;127(2):395-402.PMID: 15300570 [PubMed - indexed for MEDLINE]Related articles

Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.

Horackova M, Schück O, Komers R, Charvat J, Teplan V, Kvapil M.

Int J Clin Pharmacol Ther. 2005 Sep;43(9):413-9.PMID: 16163893 [PubMed - indexed for MEDLINE]Related articles

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

Watson DJ, Harper SE, Zhao PL, Quan H, Bolognese JA, Simon TJ.

Arch Intern Med. 2000 Oct 23;160(19):2998-3003.PMID: 11041909 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety of a specific COX-2 inhibitor in aspirin-induced asthma.

Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M.

Clin Exp Allergy. 2001 Feb;31(2):219-25.PMID: 11251623 [PubMed - indexed for MEDLINE]Related articles

Renal effects of COX-2-selective inhibitors.

Brater DC, Harris C, Redfern JS, Gertz BJ.

Am J Nephrol. 2001 Jan-Feb;21(1):1-15. Review.PMID: 11275626 [PubMed - indexed for MEDLINE]Related articles

Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.

Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ; Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group.

JAMA. 2002 Jan 2;287(1):64-71. Erratum in: JAMA 2002 Feb 27;287(8):989. PMID: 11754710 [PubMed - indexed for MEDLINE]Related articlesFree article

Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.

Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K.

Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:90-101.PMID: 11966529 [PubMed - indexed for MEDLINE]Related articlesFree article

COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.

Whelton A.

J Hypertens Suppl. 2002 Sep;20(6):S31-5. Review.PMID: 12683425 [PubMed - indexed for MEDLINE]Related articles

A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.

Malmstrom K, Fricke JR, Kotey P, Kress B, Morrison B.

Clin Ther. 2002 Oct;24(10):1549-60.PMID: 12462285 [PubMed - indexed for MEDLINE]Related articles

A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.

Hunt RH, Bowen B, Mortensen ER, Simon TJ, James C, Cagliola A, Quan H, Bolognese JA.

Am J Med. 2000 Aug 15;109(3):201-6.PMID: 10974182 [PubMed - indexed for MEDLINE]Related articles

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

Langman MJ, Jensen DM, Watson DJ, Harper SE, Zhao PL, Quan H, Bolognese JA, Simon TJ.

JAMA. 1999 Nov 24;282(20):1929-33.PMID: 10580458 [PubMed - indexed for MEDLINE]Related articlesFree article